MLICM
ACTG icon

Metropolitan Life Insurance Company (MetLife)’s Acacia Research ACTG Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ACTG Stock Details ACTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-358
Closed -$1.91K – 40
2024
Q1 		$1.91K Buy
358
+90
+34% +$376 ﹤0.01% 2291
2023
Q4 		$1.05K Sell
268
-1,824
-87% -$6.75K ﹤0.01% 2332
2023
Q3 		$7.64K Hold
2,092
– – ﹤0.01% 2328
2023
Q2 		$8.7K Buy
+2,092
New +$8.44K ﹤0.01% 2372
2022
Q1 		– Sell
-10,251
Closed -$52.6K – 2248
2021
Q4 		$52.6K Sell
10,251
-3,134
-23% -$16.9K ﹤0.01% 2695
2021
Q3 		$90.9K Buy
+13,385
New +$82K ﹤0.01% 2577
2017
Q2 		– Sell
-38,344
Closed -$220K – 2566
2017
Q1 		$220K Buy
38,344
+3,784
+11% +$22.1K ﹤0.01% 2211
2016
Q4 		$225K Sell
34,560
-3,879
-10% -$25.2K ﹤0.01% 2283
2016
Q3 		$251K Sell
38,439
-1,503
-4% -$8.66K ﹤0.01% 2194
2016
Q2 		$176K Buy
+39,942
New +$184K ﹤0.01% 2407
2016
Q1 		– Sell
-36,546
Closed -$157K – 2507
2015
Q4 		$157K Hold
36,546
– – ﹤0.01% 2411
2015
Q3 		$332K Buy
36,546
+8,242
+29% +$74.2K ﹤0.01% 1910
2015
Q2 		$248K Sell
28,304
-12,802
-31% -$131K ﹤0.01% 2256
2015
Q1 		$440K Hold
41,106
– – ﹤0.01% 1625
2014
Q4 		$696K Hold
41,106
– – ﹤0.01% 1548
2014
Q3 		$636K Hold
41,106
– – ﹤0.01% 1561
2014
Q2 		$730K Hold
41,106
– – 0.01% 1565
2014
Q1 		$628K Hold
41,106
– – ﹤0.01% 1646
2013
Q4 		$598K Hold
41,106
– – ﹤0.01% 1687
2013
Q3 		$948K Hold
41,106
– – 0.01% 1312
2013
Q2 		$919K Buy
+41,106
New +$1.03M 0.01% 1288

Other funds holding ACTG

SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ACTG Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Acacia Research (ACTG) in Q2 2024, closing a stake of 358 shares — an estimated $1.91K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ACTG in Q2 2013 and held it in 21 quarters. The position peaked at $948K in Q3 2013. 103 funds tracked by Wall St. Rank hold ACTG as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Acacia Research position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 358 Acacia Research shares in Q2 2024, an estimated $1.91K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Acacia Research in Q2 2013 and held it in 21 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Acacia Research position peaked at $948K in Q3 2013.
  • 103 funds tracked by Wall St. Rank held Acacia Research as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.